| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | JUNO THERAPEUTICS INCORPORATED | 1,375,000 | 83,407,000 | 36.07% | ||
| 2 | PARATEK PHARMACEUTICALS INC | 2,138,872 | 66,861,000 | 28.91% | ||
| 3 | Egalet Corp | 2,645,558 | 34,207,000 | 14.79% | ||
| 4 | FIBROGEN INC COM | 972,175 | 30,506,000 | 13.19% | ||
| 5 | Dicerna Pharmaceuticals | 360,447 | 8,661,000 | 3.75% | ||
| 6 | ACHAOGEN INC COM | 481,694 | 4,701,000 | 2.03% | ||
| 7 | Proteon Therapeutics | 250,000 | 2,907,000 | 1.26% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-15-005268, filed 2015.05.11).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
